Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Clinical Trials

Podcast: Operationalizing Decentralized Clinical Trials

  • Partnered Content

Decentralized clinical trials are here to stay. Explore both their advantages and their challenges from an operational perspective. Tune in now as experts share their perspectives on: 

⦁ The enduring, post-COVID benefits of the decentralized model
⦁ Operational-level challenges
⦁ Sponsor considerations in decentralized trials
⦁ Trial management concerns
⦁ Predictions for the future of decentralized studies

 

Open Media

Enjoyed this podcast? Find part one here

Table

View full table

Topics

Tags:
Clinical Trials
Latest Headlines

VC Investment Surges In Q2 As Financial Market Recovery Momentum Builds

Sutro Works Toward A Better Ovarian Cancer ADC

AstraZeneca Moves To Join Invyvid In COVID-19 Prevention

Roche’s SKYSCRAPER-06 Failure Is Another Blow For TIGIT

See All
UsernamePublicRestriction

Register

SC148983

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By